Suppressive Effect of Short-chain Fatty Acids on Production of Proinflammatory Mediators by Neutrophils
Overview
Nutritional Sciences
Affiliations
Short chain fatty acids (SCFAs) are fermentation products of anaerobic bacteria. More than just being an important energy source for intestinal epithelial cells, these compounds are modulators of leukocyte function and potential targets for the development of new drugs. The aim of this study was to evaluate the effects of SCFAs (acetate, propionate and butyrate) on production of nitric oxide (NO) and proinflammatory cytokines [tumor necrosis factor α (TNF-α) and cytokine-induced neutrophil chemoattractant-2 (CINC-2αβ)] by rat neutrophils. The involvement of nuclear factor κB (NF-κB) and histone deacetylase (HDAC) was examined. The effect of butyrate was also investigated in vivo after oral administration of tributyrin (a pro-drug of butyrate). Propionate and butyrate diminished TNF-α, CINC-2αβ and NO production by LPS-stimulated neutrophils. We also observed that these fatty acids inhibit HDAC activity and NF-κB activation, which might be involved in the attenuation of the LPS response. Products of cyclooxygenase and 5-lipoxygenase are not involved in the effects of SCFAs as indicated by the results obtained with the inhibitors of these enzymes. The recruitment of neutrophils to the peritonium after intraperitoneal administration of a glycogen solution (1%) and the ex vivo production of cytokines and NO by neutrophils were attenuated in rats that previously received tributyrin. These results argue that this triglyceride may be effective in the treatment of inflammatory conditions.
Ginsenoside Reshapes Intestinal Microecology to Alleviate Microgravity Stress.
Wang Y, Chen T, Shi Z, Dong L, Li M, Peng B Drug Des Devel Ther. 2025; 19:1289-1303.
PMID: 40026331 PMC: 11869762. DOI: 10.2147/DDDT.S486371.
The Interplay of Nutrition, the Gut Microbiota and Immunity and Its Contribution to Human Disease.
Dawson S, Todd E, Ward A Biomedicines. 2025; 13(2).
PMID: 40002741 PMC: 11853302. DOI: 10.3390/biomedicines13020329.
Rampanelli E, Romp N, Troise A, Ananthasabesan J, Wu H, Gul I Microbiome. 2025; 13(1):15.
PMID: 39833973 PMC: 11744835. DOI: 10.1186/s40168-024-02002-9.
Luangphiphat W, Prombutara P, Jamjuree P, Chantarangkul C, Vitheejongjaroen P, Muennarong C PLoS One. 2025; 20(1):e0317202.
PMID: 39792908 PMC: 11723615. DOI: 10.1371/journal.pone.0317202.
The Multifaceted Impact of Bioactive Lipids on Gut Health and Disease.
Sullivan J, Jones M Int J Mol Sci. 2025; 25(24.
PMID: 39769399 PMC: 11728145. DOI: 10.3390/ijms252413638.